Data / Research funding / North Carolina / Insoma Bio, Inc.
Insoma Bio, Inc.: 5 NIH awards ($3.1M) and 1 NSF award ($1.7M), fiscal years 2021 to 2026
Insoma Bio, Inc. in Durham, NC is funded under 5 NIH awards ($3.1M) and 1 NSF award ($1.7M) in the NIH and NSF award files, read 2026-11-03. NIH fiscal years 2021 to 2025; NSF fiscal years 2022 to 2026.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- UEI
- LF3PGT7RN6G7
- State
- North Carolina
Awards
6 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| A recombinant matrix to improve autologous tissue grafts | NIH | National Cancer Institute | 2022 to 2023 | $1,972,696 | September 11, 2019 | June 30, 2025 | ROBERTS, STEFAN | reporter.nih.gov |
| SBIR Phase II: An Injectable Protein Matrix to Enhance the Stability of Autologous Fat Grafts | NSF | Start-ups and Small Businesses Section | 2023 | $1,673,065 | September 1, 2023 | February 28, 2027 | Stefan Roberts | nsf.gov |
| Enhancing Peripheral Nerve Repair with an Injectable Recombinant Polypeptide Scaffold | NIH | National Institute of Neurological Disorders and Stroke | 2024 | $296,151 | August 1, 2024 | July 31, 2025 | ROBERTS, STEFAN | reporter.nih.gov |
| An off the shelf alternative to fat transfer for soft tissue repair | NIH | National Institute of General Medical Sciences | 2024 | $293,983 | September 1, 2024 | August 31, 2025 | ROBERTS, STEFAN | reporter.nih.gov |
| Fully defined matrices for organoid culture | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 | $290,768 | September 21, 2021 | February 28, 2023 | ROBERTS, STEFAN | reporter.nih.gov |
| A recombinant elastin skin substitute for the treatment of burns | NIH | National Institute of General Medical Sciences | 2023 | $282,373 | April 1, 2023 | March 31, 2025 | ROBERTS, STEFAN | reporter.nih.gov |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2025 | 0 | $0 | 1 | $693,868 |
| 2024 | 2 | $590,134 | 0 | $0 |
| 2023 | 2 | $1,318,252 | 1 | $979,197 |
| 2022 | 1 | $936,817 | 0 | $0 |
| 2021 | 1 | $290,768 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
Topics of its NIH awards
- Bioengineering
- Biotechnology
- Regenerative Medicine
- Transplantation
- Physical Injury - Accidents and Adverse Effects
- Stem Cell Research
- Stem Cell Research - Nonembryonic - Non-Human
- Breast Cancer
- Cancer
- Women's Health
- Wound Healing and Care
- Chronic Pain
Updated November 3, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-02). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.